The study evaluates cytotoxicity of lonidamine-1,3,4-oxadiazole derivatives in colon cancer cells, indicating potential therapeutic use.
Herein, we have employed a structure-based approach, designed and synthesized conjugates of lonidamine-1,3,4-oxadiazole, and evaluated its cytotoxicity profile on a colorectal cancer cell line.
No takes yet. Share an insight, caveat, or question.
Bhat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: